• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Danimer Scientific Announces New Directors

    1/18/24 4:30:00 PM ET
    $DNMR
    Major Chemicals
    Industrials
    Get the next $DNMR alert in real time by email

    Dr. David Moody and Richard Altice to Join the Danimer Board

    Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer's Board of Directors. Dr. Moody's appointment is effective immediately, and Mr. Altice's appointment is effective as of April 15, 2024.

    Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the medical, industrial and consumer markets. Dr. Moody previously served as Chief Executive Officer of Jadex from March 2021 through July 2023, and before that served in various roles of increasing responsibility at Milliken & Company culminating in the role of Executive Vice President and Division President, Chemicals. Dr. Moody has over thirty years' experience managing chemical and polymer related businesses in various leadership roles and holds a Bachelor of Science in Chemistry from Wofford College and a Ph.D. in Chemistry from the Georgia Institute of Technology.

    Richard N. Altice most recently retired from NatureWorks, a developer and manufacturer of biopolymers (polylactic acid), where he served as President and CEO for five years. Prior to NatureWorks, Mr. Altice was the Senior Vice President and President of PolyOne's Designed Structures and Solutions, a polymer and plastics converting and food packaging business, formerly known as Spartech. Additionally, Mr. Altice was Vice President of Hexion's Global Specialty Epoxy resin business and was formerly the President of Solutia's Technical Specialties division, responsible for the global rubber chemicals and specialty fluids businesses. Mr. Altice has over thirty years of sales, marketing, operational and management experience in the specialty chemicals and biopolymer industries and holds a Bachelor of Science in Chemical Engineering from the Missouri University of Science and Technology.

    With these changes, Danimer's Board will be comprised of eleven directors.

    "We are honored to have David and Rich join our Board of Directors," said Stephen Croskrey, Chief Executive Officer and Chairman of the Board. "Each brings valuable perspectives and experience to our Company as our proprietary biobased and biodegradable polymer, Nodax®, finds increasing applications in the market and we seek to rapidly grow our business."

    John Amboian, Lead Independent Director and Chairman of Danimer's Nominating and Corporate Governance Committee, said, "David and Rich's appointments are the culmination of a robust search process. We believe they bring the right mix of skills, perspectives, and industry-specific experience that will help Danimer execute its strategic plan and achieve its goals."

    About Danimer Scientific

    Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer's technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations. For more information, visit https://danimerscientific.com.

    Forward‐Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding our expectations for full year capital expenditures, Adjusted EBITDA and cash balances. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to our products; the Company's exposure to product liability or product warranty claims and other loss contingencies; disruptions and other impacts to the Company's business, as a result of the COVID-19 global pandemic and government actions and restrictive measures implemented in response; stability of the Company's manufacturing facilities and suppliers, as well as consumer demand for our products, in light of disease epidemics and health-related concerns such as the COVID-19 global pandemic; the impact on our business, operations and financial results from the ongoing conflict in Ukraine; the impact that global climate change trends may have on the Company and its suppliers and customers; the Company's ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, our information systems; the ability of our information technology systems or information security systems to operate effectively, including as a result of security breaches, viruses, hackers, malware, natural disasters, vendor business interruptions or other causes; our ability to properly maintain, protect, repair or upgrade our information technology systems or information security systems, or problems with our transitioning to upgraded or replacement systems; the impact of adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception; fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations; our ability to utilize potential net operating loss carryforwards; and changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks. More information on potential factors that could affect the Company's financial results is included from time to time in the Company's public reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240118429116/en/

    Get the next $DNMR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DNMR

    DatePrice TargetRatingAnalyst
    11/21/2024$40.00 → $5.50Hold
    TD Cowen
    11/20/2024$40.00 → $4.00Neutral → Underweight
    Piper Sandler
    8/13/2024$2.00 → $1.00Buy → Hold
    TD Cowen
    5/22/2024$1.30 → $0.80Buy → Hold
    Jefferies
    4/9/2024$3.50 → $1.25Overweight → Neutral
    Piper Sandler
    10/12/2022$4.50Overweight
    Piper Sandler
    9/23/2021$21.00Outperform
    Cowen
    More analyst ratings

    $DNMR
    Financials

    Live finance-specific insights

    See more
    • Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

      –Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a

      12/31/24 8:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Announces Third Quarter 2024 Results

      --Additional Resin Orders and Deliveries Continue to Support 20-Million Pound Cutlery Award –- -- 100% Compostable Skittles® Bag Made with Nodax® PHA Featured at NFL Game -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its third quarter ended September 30, 2024. Richard N. Altice, Interim Chief Executive Officer of Danimer, commented, "We completed the third quarter in line with our expectations considering the temporary impact of Starbucks' reapportionment of their Nodax-based straw business between our convert

      11/19/24 8:30:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Announces Release Date for Third Quarter 2024 Results

      Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2024 financial results before the market opens on Tuesday, November 19, 2024. A webcast and conference call will be held that same day at 10:00 a.m. Eastern Time to review the Company's third quarter results. The webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to access the webcast, the conference call will be accessible domestically o

      11/14/24 9:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Hajost Michael A converted options into 859 shares and covered exercise/tax liability with 301 shares, increasing direct ownership by 31% to 2,334 units (SEC Form 4)

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      2/10/25 4:30:05 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Director Moody David Jesse converted options into 646 shares (SEC Form 4)

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      1/21/25 4:30:10 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • SEC Form 4 filed by Director Croskrey Stephen

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      1/3/25 4:05:07 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Leadership Updates

    Live Leadership Updates

    See more
    • Danimer Scientific Announces New Directors

      Dr. David Moody and Richard Altice to Join the Danimer Board Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer's Board of Directors. Dr. Moody's appointment is effective immediately, and Mr. Altice's appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the me

      1/18/24 4:30:00 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary

      Martin, a Duke University graduate and former Air Force officer, brings experience managing the legal affairs of publicly traded companies Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market. Martin joins Danimer from Kaman Distribution Group, a leading national distributor o

      9/20/22 8:30:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Appoints Anthony Austin as Chief Human Resource Officer

      Austin brings more than 30 years of human resources leadership experience with PepsiCo, Delta Air Lines, Winn-Dixie and others Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Anthony Austin as Chief Human Resource Officer. In this role, Austin will focus on building best-in-class HR processes to strategically support the Company's growth as it continues to expand its manufacturing capacity. Austin joins Danimer from Bedrock Manufacturing Co., the parent company of Shinola, a luxury watch, leather and jewelry manufacturer an

      4/20/22 8:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

      –Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a

      12/31/24 8:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Takes Action to Strengthen Capital Structure

      Announces Issuance of $11,250,000 Super Senior Secured Promissory Note Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that the Company issued a super senior secured promissory note (the "Secured Loan") in an aggregate principal amount of $11,250,000 to certain lenders under its existing term loan financing agreement, as well as certain additional lenders. The Secured Loan provides for $11,250,000 gross proceeds, less fees and expenses. The Secured Loan has a two-year maturity and accrues interest at 15.0% per annum, which interest is payab

      12/17/24 4:15:00 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • TerraNova Capital Equities announces three transactions totaling $45 Million

      NEW YORK, Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor on three recent transactions: TerraNova Structured Finance Group acted as the sole advisor to Danimer Scientific, Inc. (NYSE:DNMR) on a $20 Million revolving credit facility. TerraNova is pleased to announce its role as the exclusive advisor to Danimer Scientific in securing a strategic ABL agreement with Mountain Ridge Capital.  This $20 million facility, collateralized by the Com

      11/20/24 10:30:00 AM ET
      $DNMR
      $INUV
      Major Chemicals
      Industrials
      Advertising
      Consumer Discretionary

    $DNMR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Hendrix Richard J bought $93,395 worth of shares (100,000 units at $0.93) (SEC Form 4)

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      11/28/23 5:35:32 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Danimer Scientific Inc.

      SC 13G - Danimer Scientific, Inc. (0001779020) (Subject)

      11/14/24 3:28:09 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Danimer Scientific Inc.

      SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

      7/8/24 4:36:39 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Danimer Scientific Inc. (Amendment)

      SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

      1/29/24 5:25:54 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on Danimer Scientific with a new price target

      TD Cowen reiterated coverage of Danimer Scientific with a rating of Hold and set a new price target of $5.50 from $40.00 previously

      11/21/24 8:09:13 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Danimer Scientific from Neutral to Underweight and set a new price target of $4.00 from $40.00 previously

      11/20/24 9:49:17 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific downgraded by TD Cowen with a new price target

      TD Cowen downgraded Danimer Scientific from Buy to Hold and set a new price target of $1.00 from $2.00 previously

      8/13/24 7:29:01 AM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    SEC Filings

    See more
    • Danimer Scientific Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

      8-K - Danimer Scientific, Inc. (0001779020) (Filer)

      3/18/25 5:00:42 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Danimer Scientific, Inc. (0001779020) (Filer)

      2/28/25 5:00:09 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Danimer Scientific Inc.

      SCHEDULE 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

      2/14/25 5:41:32 PM ET
      $DNMR
      Major Chemicals
      Industrials